RecruitingNCT02038660
Drug-Eluting Balloon Registry in Routine Clinical Practice
Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
Sponsor
Seung-Jung Park
Enrollment
1,500 participants
Start Date
Jan 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.
Eligibility
Min Age: 20 Years
Inclusion Criteria4
- After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
- Age 20 and more
- Treated with Balloon angioplasty
- Signed informed consent and agreed to follow protocol
Exclusion Criteria3
- Allergy to paclitaxel, antiplatelet
- History of side effect to heparin, aspirin, thienopyridines
- History of bleeding tendency, coagulation disorder, blood transfusion reaction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEBalloon angioplasty
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02038660
Related Trials
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT069547148 locations
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
NCT068211911 location
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
NCT072693661 location
Coronary Artery Disease Assessment Strategies in TAVI Patients
NCT065593321 location
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT058500911 location